Latest medical news · page 157

Pregnancy care is becoming more complex. Are you prepared?

Oral Ketamine for Treatment Resistant-Depression

Psychiatry

Patient Choice, Busy Health Systems, and Health Information Access

Health Informatics

Bone-Modifying Agents in Metastatic Castration-Resistant Prostate Cancer

This cohort study examines patterns of bone-modifying agent use from 2013 to 2024 among men with metastatic castration-resistant prostate cancer.

Patient Perspectives on Electronic Communication of Cancer Diagnoses

This survey study investigates patient experiences and preferences regarding the electronic communication of cancer diagnoses.

Oral Prolonged-Release Ketamine for Treatment-Resistant Depression

These randomized clinical trials—a phase 1 crossover trail and a phase 2 placebo-controlled trial—examine the dissociative adverse effects of a prolonged-release oral ketamine tablet formulation and its outpatient efficacy at reducing symptoms of treatment-resistant depression.

RBC Transfusions, Morbidity, and Mortality in Very-Low-Birth-Weight Infants

This cohort study examines whether blood donor, red blood cell (RBC) modifications and storage, or transfusion thresholds or characteristics are associated with serious adverse outcomes in very-low-birth-weight infants receiving RBC transfusion.

Virtual Care Remuneration Policy and Postdischarge Follow-Up Trends

This cross-sectional study examines whether a system-wide virtual care remuneration policy was associated with changes in 7-day postdischarge follow-up rates overall and by hospitalization type, patient rurality, and socioeconomic status.

Prenatal Acid-Suppressive Drug Exposure and Offspring Inflammatory Bowel Disease

This cohort study evaluates the association between prenatal exposure to acid-suppressive medications and the risk of inflammatory bowel disease using a nationwide birth cohort in South Korea.

Trust in Cancer Information Sources and Awareness of HPV as a Cause of Cancer

This cross-sectional study assesses the association of trust in cancer information sources with awareness that human papillomavirus causes cervical cancer among US adults.

Population-Level Trends in Asthma Exacerbations After Introduction of Respiratory Biologics

This cohort study analyzes population-level changes in asthma exacerbations after the rapid approval of respiratory biologics in 2015.

Adolescent Suicidality After State-Level Total Abortion Bans

This cross-sectional study evaluates whether implementation of total abortion bans was associated with suicidal ideation and suicide attempts among female high school students participating in Youth Risk Behavior Surveys from 2017 to 2023.

Comprehensive Smoke-Free Laws and Cardiovascular Disease Mortality

This comparative effectiveness research study evaluates the long-term association between comprehensive smoke-free laws and county-level cardiovascular disease mortality and assesses whether these associations vary by age, sex, and race and ethnicity.

Startup Raises $7M for Virtual-First Pediatric Therapy Model

Ladder Health’s seed round was led by Nina Capital, with participation from Mairs & Power Venture Capital, South Dakota First Capital, 25madison Health, Hatteras Venture Partners, Create Health Ventures, Jumpstart Capital, White Oak Enterprises, Groove Capital and 7Rock Ventures. The post Startup Raises $7M for Virtual-First Pediatric Therapy Model appeared first on MedCity News .

IND Application Reporting: IND Safety Reports

This webpage provides an overview of investigational new drug application (IND) safety reporting requirements for sponsors set forth in 21 CFR 312.32 and additional resources, including FDA guidances, related to these requirements.

Guidance Recap Podcast | Digital Health Technologies for Remote Data Acquisition in Clinical Investigations

Guidance Recap Podcast | Digital Health Technologies for Remote Data Acquisition in Clinical Investigations

ACP, Annals forum addressed care of patients on GLP-1 receptor agonists

ACP and Annals of Internal Medicine presented a virtual live forum on care of patients on glucagon-like peptide-1 (GLP-1) receptor agonists on June 17.

Guidance Snapshot Pilot

Guidance Snapshots are a communication tool that provide highlights from the document using visuals and plain language. This pilot program is intended to increase awareness for FDA guidance documents to support the efficient application of the documents’ recommendations.

Personal protective equipment and heat: risk of heat stress

This is an urgent public health message to health and care providers and professionals regarding the risk of heat stress when using PPE.

Medtronic appoints veteran J&J exec as first CFO of innovation

Eric Lenard comes to the new position with more than two decades of experience in medtech finance, as Medtronic steps up its investment in innovation.

Single vs. Double TSP in AFib Ablation Yields Comparable Outcomes | NCDR Study

Among patients undergoing atrial fibrillation (AFib) ablation, single and double transeptal puncture (TSP) exhibited similar procedural safety and likelihood of discharge in sinus rhythm, according to a recent study published in the Journal of Interventional Cardiac Electrophysiology.

Genotype Independently Predicts HF Outcomes in Patients With HCM

In patients with hypertrophic cardiomyopathy (HCM), genotype, peak VO2, log NT-proBNP and LVEF independently predict heart failure (HF) outcomes, and combining these measures identified patients at higher risk of HF-related death or transplant, according to a recent study published in JACC: Heart Failure.

Official Statistics: National norovirus and rotavirus report, week 27 report: data to week 26 (data up to 28 June 2026)

Summary of norovirus and rotavirus laboratory surveillance and enteric virus outbreaks in England during the 2025 to 2026 season.

Accredited official statistics: Monthly mandatory surveillance of MRSA, MSSA, Gram-negative bacteraemia and C. difficile infections, May 2025 to May 2026

Mandatory surveillance of healthcare-associated infections (HCAI), which include methicillin-resistant Staphylococcus aureus (MRSA), Methicillin-sensitive Staphylococcus aureus (MSSA), Gram-negative bacteraemia such as Escherichia coli (E. coli), Klebsiella and Pseudomonas aeruginosa (P. aeruginosa) and Clostridioides difficile (C. difficile, or CDI): May 2025 to May 2026.